{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:04:48Z","timestamp":1792800288506,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Chang Gung Medical Research Program","award":["CMRPG3C0371, CMRPG3C0372, CMRPG3C0373"],"award-info":[{"award-number":["CMRPG3C0371, CMRPG3C0372, CMRPG3C0373"]}],"id":[{"id":"https:\/\/ror.org\/02verss31","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-017-0957-4","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T06:57:59Z","timestamp":1505113079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Phenotypic expressions of hereditary Transthyretin Ala97Ser related Amyloidosis (ATTR) in Taiwanese"],"prefix":"10.1186","volume":"17","author":[{"given":"Hui-Ching","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Feng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Lung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Lun","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chou","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Kuo","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Chien-Chia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sun","family":"Ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,7]]},"reference":[{"issue":"12","key":"957_CR1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plant\u00e9-Bordeneuve","year":"2011","unstructured":"Plant\u00e9-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10(12):1086\u201397.","journal-title":"Lancet Neurol"},{"issue":"7","key":"957_CR2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrcardio.2010.67","volume":"7","author":"C Rapezzi","year":"2010","unstructured":"Rapezzi C, Quarta CC, Riva L, Longhi S, Gallelli I, Lorenzini M, Ciliberti P, Biagini E, Salvi F, Branzi A. Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol. 2010;7(7):398\u2013408.","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"957_CR3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrgastro.2009.147","volume":"6","author":"PT Sattianayagam","year":"2009","unstructured":"Sattianayagam PT, Hawkins PN, Gillmore JD. Systemic amyloidosis and the gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2009;6(10):608\u201317.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"957_CR4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.58.7.1001","volume":"58","author":"S Ikeda","year":"2002","unstructured":"Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology. 2002;58(7):1001\u20137.","journal-title":"Neurology"},{"key":"957_CR5","doi-asserted-by":"publisher","unstructured":"Ando Y, Coelho T, Berk JL, Cruz MW, Ericzon BG, Ikeda SI, Lewis WD, Obici L, Plant\u00e9-Bordeneuve V, Rapezzi C, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013; doi:\n10.1186\/1750-1172-8-31.1\n\n.","DOI":"10.1186\/1750-1172-8-31.1"},{"issue":"6","key":"957_CR6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1212\/WNL.0b013e3181ec7fda","volume":"75","author":"NC Yang","year":"2010","unstructured":"Yang NC, Lee MJ, Chao CC, Chuang YT, Lin WM, Chang MF, Hsieh PC, Kan HW, Lin YH, Yang CC, et al. Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser. Neurology. 2010;75(6):532\u20138.","journal-title":"Neurology"},{"issue":"1\u20132","key":"957_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jns.2007.10.011","volume":"267","author":"YT Liu","year":"2008","unstructured":"Liu YT, Lee YC, Yang CC, Chen ML, Lin KP. Transthyretin Ala97Ser in Chinese-Taiwanese patients with familial amyloid polyneuropathy: genetic studies and phenotype expression. J Neuro Sci. 2008;267(1\u20132):91\u20139.","journal-title":"J Neuro Sci"},{"issue":"2","key":"957_CR8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ana.24438","volume":"78","author":"CC Chao","year":"2015","unstructured":"Chao CC, Huang CM, Chiang HH, Luo KR, Kan HW, Yang NCC, Chiang H, Lin WM, Lai SM, Lee MJ, et al. Sudomotor innervation in transthyretin amyloid neuropathy: pathology and functional correlates. Ann Neurol. 2015;78(2):272\u201383.","journal-title":"Ann Neurol"},{"issue":"2","key":"957_CR9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrneurol.2014.263","volume":"11","author":"S Mead","year":"2015","unstructured":"Mead S, Reilly MM. A new prion disease: relationship with central and peripheral amyloidoses. Nat Rev Neurol. 2015;11(2):90\u20137.","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"957_CR10","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1007\/s00415-013-7051-7","volume":"260","author":"T Coelho","year":"2013","unstructured":"Coelho T, Maia LF, Da Silva AM, Cruz MW, Plant\u00e9-Bordeneuve V, Suhr OB, Concei\u00e7ao I, Schmidt HHJ, Trigo P, Kelly JW, et al. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol. 2013;260(11):2802\u201314.","journal-title":"J Neurol"},{"issue":"8","key":"957_CR11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","volume":"79","author":"T Coelho","year":"2012","unstructured":"Coelho T, Maia LF, Da Silva AM, Cruz MW, Plant\u00e9-Bordeneuve V, Lozeron P, Suhr OB, Campistol JM, Concei\u00e7\u00e3o IM, Schmidt HHJ, et al. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology. 2012;79(8):785\u201392.","journal-title":"Neurology"},{"issue":"2","key":"957_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1096-8628(19980501)77:2<135::AID-AJMG5>3.0.CO;2-R","volume":"77","author":"MC Patrosso","year":"1998","unstructured":"Patrosso MC, Salvi F, De Grandis D, Vezzoni P, Jacobson DR, Ferlini A. Novel transthyretin missense mutation (Thr34) in an Italian family with hereditary amyloidosis. Am J Med Genet. 1998;77(2):135\u20138.","journal-title":"Am J Med Genet"},{"issue":"suppl 3","key":"957_CR13","first-page":"iii31","volume":"74","author":"CJ Mathias","year":"2003","unstructured":"Mathias CJ. Autonomic diseases: clinical features and laboratory evaluation. J Neurol Neurosurg Psychiatry. 2003;74(suppl 3):iii31\u201341.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"957_CR14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","volume":"120","author":"C Rapezzi","year":"2009","unstructured":"Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, Salvi F, Ciliberti P, Pastorelli F, Biagini E, et al. Systemic cardiac Amyloidoses. Circulation. 2009;120(13):1203\u201312.","journal-title":"Circulation"},{"issue":"3","key":"957_CR15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12574-015-0249-1","volume":"13","author":"F Cacciapuoti","year":"2015","unstructured":"Cacciapuoti F. The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis. J Echocardiogr. 2015;13(3):84\u20139.","journal-title":"J Echocardiogr"},{"issue":"7","key":"957_CR16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","volume":"34","author":"C Rapezzi","year":"2013","unstructured":"Rapezzi C, Quarta CC, Obici L, Perfetto F, Longhi S, Salvi F, Biagini E, Lorenzini M, Grigioni F, Leone O, et al. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. Eur Heart J. 2013;34(7):520\u20138.","journal-title":"Eur Heart J"},{"issue":"7","key":"957_CR17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/01.wnl.0000267338.45673.f4","volume":"69","author":"V Plante-Bordeneuve","year":"2007","unstructured":"Plante-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, Said G. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology. 2007;69(7):693\u20138.","journal-title":"Neurology"},{"issue":"12","key":"957_CR18","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1007\/s00415-013-7124-7","volume":"260","author":"MF Dohrn","year":"2013","unstructured":"Dohrn MF, R\u00f6cken C, De Bleecker JL, Martin JJ, Vorgerd M, Van Den Bergh PY, Ferbert A, Hinderhofer K, Schr\u00f6der JM, Weis J, et al. Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy. J Neurol. 2013;260(12):3093\u2013108.","journal-title":"J Neurol"},{"issue":"18","key":"957_CR19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/eurheartj\/ehu506","volume":"36","author":"RH Sayed","year":"2015","unstructured":"Sayed RH, Rogers D, Khan F, Wechalekar AD, Lachmann HJ, Fontana M, Mahmood S, Sachchithanantham S, Patel K, Hawkins PN, et al. A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis. Eur Heart J. 2015;36(18):1098\u2013105.","journal-title":"Eur Heart J"},{"issue":"9","key":"957_CR20","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0002-9149(97)00653-X","volume":"80","author":"B Chamarthi","year":"1997","unstructured":"Chamarthi B, Dubrey SW, Cha K, Skinner M, Falk RH. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol. 1997;80(9):1242\u20135.","journal-title":"Am J Cardiol"},{"issue":"2","key":"957_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2169\/internalmedicine.56.7562","volume":"56","author":"C Sato","year":"2017","unstructured":"Sato C, Takaya T, Mori S, Hasegawa K, Soga F, Tanaka H, Watanabe Y, Nishii T, Kono AK, Morinaga Y, et al. An isolated case of late-onset amyloidogenic transthyretin type familial amyloid polyneuropathy associated with a mutant transthyretin substituting methionine for valine at position 30 showing latent progressive cardiac involvement confirmed by serial annual electrocardiograms. Intern Med. 2017;56(2):163\u20138.","journal-title":"Intern Med"},{"issue":"6","key":"957_CR22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1440-1827.1997.tb04508.x","volume":"47","author":"K Takahashi","year":"1997","unstructured":"Takahashi K, Sakashita N, Ando Y, Suga M, Ando M. Late onset type I familial amyloidotic polyneuropathy: presentation of three autopsy cases in comparison with 19 autopsy cases of the ordinary type. Pathol Int. 1997;47(6):353\u20139.","journal-title":"Pathol Int"},{"issue":"1","key":"957_CR23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000132966.36437.12","volume":"63","author":"H Koike","year":"2004","unstructured":"Koike H, Misu K, Sugiura M, Iijima M, Mori K, Yamamoto M, Hattori N, Mukai E, Ando Y, Ikeda S, et al. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology. 2004;63(1):129\u201338.","journal-title":"Neurology"},{"key":"957_CR24","doi-asserted-by":"publisher","unstructured":"Ishida K, Nishida T, Niimi Y, Suemori S, Mochizuki K, Kawakami H, Kimura A, Hirayama T. Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries. Ophthalmic Genet. 2017; doi:\n10.1080\/13816810.2016.1232413.1-5\n\n.","DOI":"10.1080\/13816810.2016.1232413.1-5"},{"key":"957_CR25","doi-asserted-by":"publisher","unstructured":"Coelho T, Vinik A, Vinik EJ, Tripp T, Packman J, Grogan DR. Clinical measures in transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2016; doi:\n10.1002\/mus.25257\n\n.","DOI":"10.1002\/mus.25257"},{"issue":"24","key":"957_CR26","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, et al. Nonbiopsy diagnosis of cardiac Transthyretin Amyloidosis. Circulation. 2016;133(24):2404\u201312.","journal-title":"Circulation"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-017-0957-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T06:58:04Z","timestamp":1505113084000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-017-0957-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["957"],"URL":"https:\/\/doi.org\/10.1186\/s12883-017-0957-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,7]]},"article-number":"178"}}